Diagnostics

News and analysis on diagnostic technologies and applications.

Over the next month the company plans to expand its preconception screening test, which it launched widely earlier this year, by adding about 90 X-linked disorders. 

The company recently raised $8 million and is looking to partner with other firms interested in antigen discovery and diagnostic development. 

Researchers are working with the Australian Ministry of Health to commercialize a diagnostic test that employs the biomarker and could be available within two to five years.

The distribution deal comes less than a month after the firm announced that the FDA cleared for marketing the revogene instrument along with the GenePOC GBS LB assay. 

SOL will help Personal Genomics to further develop its research projects and implement its new facility dedicated to DNA sequencing.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.